Purpose: To determine the value of combined positron emission tomography/computed tomography (PET/CT) during induction chemotherapy (CTx) followed by chemoradiotherapy (CTx/ RTx) for non^small-cell lung cancer to predict histopathologic response in primary tumor and mediastinum and prognosis of the patient. Experimental Design: Fifty consecutive patients with locally advanced non^small-cell lung cancer received induction therapy and, if considered resectable, proceeded to surgery (37 of 50 patients). Patients had at least two repeated 18 F-2-fluoro-2-deoxy-D-glucose (FDG)-PET/CT scans either before treatment (t 0 ) or after induction CTx (t 1 ) or CTx/RTx (t 2 ).Variables from the PET/CTstudies [e.g., lesion volume and corrected maximum standardized glucose uptake values (SUV max,corr )] were correlated with histopathologic response (graded as 3, 2b, or 2a: 0%, >0-10%, or >10% residual tumor cells) and times to failure.Results: Primary tumors showed a percentage decrease in SUV max,corr during induction significantly larger in grade 2b/3 than in grade 2a responding tumors (67% versus 34% at t 1 , 73% versus 49% at t 2 ; both P < 0.005). SUV max,corr at t 2 was significantly correlated with histopathologic response in tumors smaller than the median volume (7.5 cm 3 ; r = À0.54, P = 0.02). In the mediastinal lymph nodes, SUV max,corr values at t 2 predicted an ypN 0 status with a sensitivity and specificity of 73% and 89%, respectively (SUV max,corr threshold of 4.1, r = À0.54, P = 0.0005). Freedom from extracerebral relapse was significantly better in grade 2b/3 patients (86% at16 months versus 20% in 2a responders; P = 0.003) andinpatients with a greater percentage decrease in SUV max,corr in the primary tumor at t 2 in relation to t 0 than in patients with lesser response (83% at 16 months versus 43%; P = 0.03 for cutoff points between 0.45 and 0.55). Conclusions: SUV max,corr values from two serial PET/CT scans, before and after three chemotherapy cycles or later, allow prediction of histopathologic response in the primary tumor and mediastinal lymph nodes and have prognostic value.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.